Detailed price information for Amphastar Pharma (AMPH-Q) from The Globe and Mail including charting and trades.
According to IQVIA, the U.S. sales for Atrovent ® HFA were approximately $112 million for the 12 months ended December 31, 2025. Amphastar plans to launch its Ipratropium Bromide HFA Inhalation ...
RANCHO CUCAMONGA, CA / ACCESS Newswire / February 24, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results